We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Thermo Fisher Scientific - Direct Effect Media

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Tele-Ultrasound Device Allows Pregnant Women to Scan at Home

By HospiMedica International staff writers
Posted on 19 Aug 2020
Print article
The PulseNmore dockable ultrasound solution (Photo courtesy of PulseNmore)
The PulseNmore dockable ultrasound solution (Photo courtesy of PulseNmore)
A handheld device enables pregnant women to perform ultrasound scans on themselves and receive feedback from a physician or sonographer.

The PulseNmore (Omer, Israel) device docks with a smartphone and utilizes advanced navigation and artificial intelligence (AI) tools, as well as an app, to guide users through the scanning process. The high-quality images can be shared with physicians or sonographers, who can review the scans remotely in real-time or off-line using telemedicine platforms. The device provides peace of mind, and can help reduce the number of prenatal office visits, especially useful during the COVID-19 pandemic.

The user’s smartphone provides the initial computational power, screen, and connectivity; the images are analyzed in the cloud. Clalit Health Services (Tel Aviv, Israel), Israel's largest health maintenance organization (HMO) and the one of the largest public HMOs in the world, with 4.6 million insured members, is the first healthcare provider to purchase the device, signing a multi-year agreement to provide tens of thousands of its pregnant members with the device, which is designed for a cycle of 25-50 scans.

“We have successfully miniaturized the traditional ultrasound system to create a solution that is both affordable and accessible for expectant families,” said Elazar Sonnenschein, MD, founder and CEO of PulseNmore. “According to Clalit, pregnant women pay ‘false’ visits to the emergency room more than twice on average with concerns about their baby's well-being. Our solution provides vital information to healthcare providers to determine if a baby is healthy, helping expectant mothers have peace of mind at home and avoid unnecessary visits to the ER.”

“Clalit's physicians reviewed more than 1,300 self-scans in our initial study with PulseNmore and clearly saw fetal heart activity, movement, and amniotic fluid in 95% of the scans,” said Leor Wolff, head of translational innovation and eHealth at Clalit Health Services. “We are confident that PulseNmore's device will support our healthcare professionals during COVID-19 and beyond, while enhancing the pregnancy experience and satisfaction for our members.”

Related Links:

Clalit Health Services

Print article


Surgical Techniques

view channel
Image: Robotic surgery has been found to improve patient recovery time (Photo courtesy of Pexels)

Robotic Surgery Found to Be Safer, Reduces Patient Time in Hospital

Unlike open surgery, where a surgeon works directly on a patient and involves large incisions in the skin and muscle, robot-assisted surgery allows surgeons to guide minimally invasive instruments remotely... Read more

Patient Care

view channel
Image: Future wearable health tech could measure gases released from skin (Photo courtesy of Pexels)

Wearable Health Tech Could Measure Gases Released From Skin to Monitor Metabolic Diseases

Most research on measuring human biomarkers, which are measures of a body’s health, rely on electrical signals to sense the chemicals excreted in sweat. But sensors that rely on perspiration often require... Read more

Health IT

view channel
Image: AI can reveal a patient`s heart health (Photo courtesy of Mayo Clinic)

AI Trained for Specific Vocal Biomarkers Could Accurately Predict Coronary Artery Disease

Earlier studies have examined the use of voice analysis for identifying voice markers associated with coronary artery disease (CAD) and heart failure. Other research groups have explored the use of similar... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.